title: Evaluation of CD62L expression as a marker for vaccine-elicited memory cytotoxic T lymphocytes.
abstract: The development of successful vaccination strategies for eliciting cytotoxic T lymphocytes (CTLs) will be facilitated by the definition of strategies for subdividing CTLs into functionally distinct subpopulations. We assessed whether surface expression of a number of cell-surface proteins could be used to define functionally distinct subpopulations of memory CTLs in mice immunized with a recombinant vaccinia virus expressing human immunodeficiency virus (HIV)-1 envelope (Env). We found changes in cell-surface expression of CD11a, CD44, CD45RB, CD49d, CD54 and CD62L on Env-specific CD8(+) T cells that appeared to differentiate them from other CD8(+) T cells within 1 week to 1 month following immunization. Further, we saw an up-regulation of CD62L surface expression on Env-specific CD8(+) memory T cells several months after immunization. However, CD62L expression did not correlate with differences in the abilities of CTLs to proliferate or produce interferon gamma (IFN-gamma) and tumour necrosis factor alpha (TNF-alpha) in vitro in response to Env peptide stimulation. Moreover, the expression of CD62L did not allow differentiation of CTLs into subpopulations with distinct expansion kinetics in vivo after adoptive transfer into naïve mice and subsequent boosting of these mice with a recombinant adenovirus expressing HIV-1 Env. Therefore, the definition of memory CD8(+) T-cell subpopulations on the basis of CD62L expression in mice does not allow the delineation of functionally distinct CTL subpopulations.
authors.affiliation: Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
authors.forename: Shawn S
authors.initials: SS
authors.lastname: Jackson
authors.forename: Jörn E
authors.initials: JE
authors.lastname: Schmitz
authors.forename: Marcelo J
authors.initials: MJ
authors.lastname: Kuroda
authors.forename: Paul F
authors.initials: PF
authors.lastname: McKay
authors.forename: Shawn M
authors.initials: SM
authors.lastname: Sumida
authors.forename: Kristi L
authors.initials: KL
authors.lastname: Martin
authors.forename: Faye
authors.initials: F
authors.lastname: Yu
authors.forename: Michelle A
authors.initials: MA
authors.lastname: Lifton
authors.forename: Darci A
authors.initials: DA
authors.lastname: Gorgone
authors.forename: Norman L
authors.initials: NL
authors.lastname: Letvin
mesh_terms: D016915:AIDS Vaccines / Q000276:immunology*; D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D049109:Cell Proliferation; D005260:Female; D007156:Immunologic Memory; D016130:Immunophenotyping; D007371:Interferon-gamma / Q000096:biosynthesis; D019041:L-Selectin / Q000378:metabolism*; D008213:Lymphocyte Activation; D051379:Mice; D008807:Mice, Inbred BALB C; D013154:Spleen / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis; D014611:Vaccination
chemical_list: D016915:AIDS Vaccines; D015415:Biomarkers; D014409:Tumor Necrosis Factor-alpha; D019041:L-Selectin; D007371:Interferon-gamma